Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial.

• Authors: Vappu Rantalaiho, Hannu Kautiainen, Markku Korpela, Kari Puolakka, Harri Blåfield, Kirsti Ilva, Pekka Hannonen, Marjatta Leirisalo-Repo, Timo Möttönen, FIN-RACo Study Group
• Journal: Annals of the rheumatic diseases (Ann Rheum Dis) Vol. 73 Issue 4 Pg. 788-90 (Apr 2014) ISSN: 1468-2060 [Electronic] England
• PMID: 24297374 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Antirheumatic Agents
• Glucocorticoids
• Prednisolone

Topics

• Antirheumatic Agents (therapeutic use)
• Arthritis, Rheumatoid (drug therapy)
• Drug Monitoring
• Drug Therapy, Combination
• Glucocorticoids (therapeutic use)
• Humans
• Prednisolone (therapeutic use)
• Remission Induction